Too often, physicians are reluctant to give patients a diagnosis of dementia, even when cognitive testing shows memory loss or other symptoms. And when doctors do provide a candid diagnosis, they may send their patients and their families home without any guidance for what to do next. No practical advice. No sense of hope. And too often, not even any [...]
The federal agency that operates Medicare, the Centers for Medicare and Medicaid Services (CMS), is finally recognizing what families have known for, well, thousands of years: Family members are the bedrock of the system of care for frail older adults and younger people with disabilities. And the agency is taking some important steps to help them. Some proposals will provide [...]
Living with memory loss and other cognitive limitations is hard. But when you can’t remember or can’t process information well enough to make important decisions, and you have no one by your side to support you, life can be extra tough. Researchers at the University of California San Francisco ((UCSF) estimate that about 4.3 million older adults with cognitive impairment [...]
The Food and Drug Administration (FDA) has granted final approval to the anti-Alzheimer’s drug lecanamab, marked as Leqembi by drugmakers Eisai and Biogen. Here is what you need to know: What does it do? In a formal phase 3 trial, Leqembi was shown to slow the progression of memory loss and cognitive impairment in patients with early-stage Alzheimer’s disease by [...]
Enormous attention is being given to controversial drugs aimed at slowing the progression of early-stage Alzheimer’s disease. Yet, a very different set of clinical innovations holds the promise of helping far more people living with dementia and their families in more immediate—and perhaps more effective—ways. These care delivery models are aimed at breaking down the often-impenetrable barriers between health care [...]
The sponsors of the House Republican debt limit bill, the Limit, Save, Grow Act, say its goal is to encourage low-income people to work. But it may have exactly the opposite effect, especially for people with disabilities. And, at the same time, it may throw family caregivers into an impossible situation—having to choose between caring for their loved ones or [...]
New government projections estimate significant increases in both overall and out-of-pocket costs for home care, nursing facilities, and continuing care communities (CCRCs) through this decade. The projected steep rise in costs will lead to tough decisions for both consumers and government. The latest annual projections, by analysts at the federal Centers for Medicare and Medicaid Services (CMS) forecast overall health [...]
The FDA’s decision to grant accelerated approval for the anti-Alzheimer’s drug lecanemab, which will be sold as Leqembi, has significant potential for research into treatment of the disease. But people living with Alzheimer’s and their families will face difficult choices once the drug is made available later this month by Biogen and the Japanese firm Eisai. A trial found the [...]
When Congress returns for a short post-election session, one item on its to-do list is major retirement savings legislation that has broad bipartisan support. One feature of both House and Senate bills: Expanding a deferred annuity called a Qualified Longevity Annuity Contract (QLAC). Both bills would increase the allowable size of QLACs. That might make them more attractive to some [...]
Imagine, for a moment, a functioning, well-developed system for improving the lives of frail older adults. Imagine that, instead of our current chaotic, dangerous, and needlessly expensive patchwork of care for seniors, the US had a well-coordinated care model that leverages and supports paid aides, family caregivers, safe and appropriate housing, and new technology. And imagine a system that makes [...]